MetSyn is a probiotic complex by SynBalance, specifically formulated to support individuals with metabolic syndrome. A randomized, double-blind, placebo-controlled clinical trial demonstrated its ability to improve key metabolic and inflammatory markers, while also enhancing lipid and cholesterol profiles, underscoring the added value of probiotic supplementation alongside lifestyle modifications. Additionally, recent in vitro studies have revealed its efficacy against the harmful stimuli associated with dysbiosis and increased intestinal permeability, with a particular focus on their impact on vascular health, implying a possible positive impact on cardiovascular conditions, including hypertension and endothelial dysfunction.
- > SynbÆctive® MetSyn
SynbÆctive® MetSyn
Discover characteristics, functionalities and scientific support of SynbÆctive® MetSyn.
Thearapeutical Area(s): Cardiometabolic
Age/Gender: Adults
Dosage Form: sachets, capsule, sticks, tablets, triphase vials, bulk
CFU/Dose: 6 billion(s)
Scientific reference(s)
Cicero, Arrigo FG, et al. “Impact of a short term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo controlled clinical trial.” European journal of nutrition (2020).
V. Mezzasalma et al., “A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation” BioMed Research International, 2016.
The most performin strain have been selected though different specific in-vitro models, as the downregulation of inflammation and the modulation of the enzymes involved in lipid and carbohydrates metabolism
